As an endothelial cell-specific mitogen, vascular endothelial growth factor (VEGF) can trigger physiological and pathological angiogenesis, which influences the host’s immune response to tumors and impacts immune cell function in the tumor microenvironment [91,92]. The gene discussed is VEGFA; the disease is neoplasm.